Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 5 g | Available to ship TODAYfromMILWAUKEE | $84.90 |
About This Item
Linear Formula:
CF3(CF2)7Br
CAS Number:
Molecular Weight:
498.96
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
207-028-4
Beilstein/REAXYS Number:
2016022
MDL number:
Assay:
99%
Form:
liquid
Quality Segment
assay
99%
form
liquid
refractive index
n20/D 1.305 (lit.)
bp
142 °C (lit.)
density
1.93 g/mL at 25 °C (lit.)
functional group
bromo, fluoro
SMILES string
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br
InChI
1S/C8BrF17/c9-7(22,23)5(18,19)3(14,15)1(10,11)2(12,13)4(16,17)6(20,21)8(24,25)26
InChI key
WTWWXOGTJWMJHI-UHFFFAOYSA-N
General description
1-Bromoheptadecafluorooctane (perfluorooctyl bromide) is a perfluorocarbon. Poly(ethylene glycol)ylated polyester nanocapsules of perfluorooctyl bromide were surface-decorated with a RGD (arginine-glycine-aspartic acid) peptide, were used for tumor imaging.[1] Nanocapsules of perfluorooctyl bromide have been developed as dual contrast agent for ultrasonography and Magnetic Resonance Imaging (MRI).
Application
1-Bromoheptadecafluorooctane (perfluorooctyl bromide) can be used as contrast agent in the vascular system for fluorine-19 magnetic resonance imaging or as synthetic oxygen carrier.[2] It was also employed as oxygen carrier in the emulsions used as blood substitutes.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
S A Snyder et al.
Veterinary and comparative oncology, 6(4), 213-223 (2009-01-31)
Human oncology has clearly demonstrated the existence of hypoxic tumours and the problematic nature of those tumours. Hypoxia is a significant problem in the treatment of all types of solid tumours and a common reason for treatment failure. Hypoxia is
Sabah Servaes et al.
Pediatric radiology, 39(4), 393-395 (2009-02-04)
Partial liquid ventilation therapy utilizing perfluorocarbons has been used for patients with severe respiratory distress. Perfluorocarbons such as perflubron have been demonstrated to clear from the lungs shortly after therapy. We present a 13-year-old boy with residual perflubron in his
Journal of Fluorine Chemistry, 114, 119-126 (2002)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 343862-5G | 04061837072925 |
